{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T19:07:35Z","timestamp":1787857655413,"version":"build-2784847793"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.contraception.2004.10.001","type":"journal-article","created":{"date-parts":[[2005,2,11]],"date-time":"2005-02-11T04:35:31Z","timestamp":1108096531000},"page":"89-94","source":"Crossref","is-referenced-by-count":15,"title":["Steroid hormones for contraception in men: systematic review of randomized controlled trials"],"prefix":"10.1016","volume":"71","author":[{"given":"David A.","family":"Grimes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria F.","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Grigorieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Nanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth F.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2004.10.001_bib1","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nm0496-398","article-title":"The myth of a male pill","volume":"2","author":"Potts","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.contraception.2004.10.001_bib2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1258\/0007142001903300","article-title":"Hormonal contraception in the male","volume":"56","author":"Anderson","year":"2000","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.contraception.2004.10.001_bib3","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3109\/07853890109002104","article-title":"Advances in male hormonal contraception","volume":"33","author":"Anawalt","year":"2001","journal-title":"Ann. Med."},{"key":"10.1016\/j.contraception.2004.10.001_bib4","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0015-0282(16)58166-7","article-title":"Effects of testosterone enanthate in normal men: experience from a multicenter contraceptive efficacy study. World Health Organization Task Force on Methods for the Regulation of Male Fertility","volume":"65","author":"Wu","year":"1996","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.contraception.2004.10.001_bib5","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1210\/jc.84.10.3642","article-title":"A clinical trial of injectable testosterone undecanoate as a potential male contraceptive in normal Chinese men","volume":"84","author":"Zhang","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.contraception.2004.10.001_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0010-7824(79)90084-2","article-title":"Pregnancies associated with sperm concentrations below 10 million\/ml in clinical studies of a potential male contraceptive method, monthly depot medroxyprogesterone acetate and testosterone esters","volume":"20","author":"Barfield","year":"1979","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2004.10.001_bib7","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0140-6736(90)92416-F","article-title":"Contraceptive efficacy of testosterone-induced azoospermia in normal men","volume":"336","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2004.10.001_bib8","first-page":"338","article-title":"Male contraception","volume":"2","author":"Jensen","year":"2002","journal-title":"Curr. Womens Health Rep."},{"key":"10.1016\/j.contraception.2004.10.001_bib9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1046\/j.1365-2605.2001.00319.x","article-title":"Combination of subcutaneous levonorgestrel implants and transdermal dihydrotestosterone gel for male hormonal contraception","volume":"24","author":"Pollanen","year":"2001","journal-title":"Int. J. Androl."},{"key":"10.1016\/j.contraception.2004.10.001_bib10","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1210\/jc.87.2.530","article-title":"An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations","volume":"87","author":"Kamischke","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.contraception.2004.10.001_bib11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1210\/jc.74.1.84","article-title":"Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception","volume":"74","author":"Behre","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.contraception.2004.10.001_bib12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/j.1939-4640.2001.tb02157.x","article-title":"Suppression of spermatogenesis with desogestrel and testosterone pellets is not enhanced by addition of finasteride","volume":"22","author":"Kinniburgh","year":"2001","journal-title":"J. Androl."},{"key":"10.1016\/j.contraception.2004.10.001_bib13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/j.1939-4640.1999.tb02535.x","article-title":"A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic effects than higher dosage combinations","volume":"20","author":"Anawalt","year":"1999","journal-title":"J. Androl."},{"key":"10.1016\/j.contraception.2004.10.001_bib14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0015-0282(00)01490-4","article-title":"Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and high-density lipoprotein suppression","volume":"74","author":"Anawalt","year":"2000","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.contraception.2004.10.001_bib15","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1210\/jc.87.8.3640","article-title":"Suppression of spermatogenesis by etonogestrel implants with depot testosterone: potential for long-acting male contraception","volume":"87","author":"Anderson","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.contraception.2004.10.001_bib16","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1093\/humrep\/17.11.2869","article-title":"Investigation of hormonal male contraception in African men: suppression of spermatogenesis by oral desogestrel with depot testosterone","volume":"17","author":"Anderson","year":"2002","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.contraception.2004.10.001_bib17","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/humrep\/15.7.1515","article-title":"Dose-finding study of oral desogestrel with testosterone pellets for suppression of the pituitary\u2013testicular axis in normal men","volume":"15","author":"Martin","year":"2000","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.contraception.2004.10.001_bib18","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1210\/jc.87.8.3562","article-title":"Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone","volume":"87","author":"Gonzalo","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.contraception.2004.10.001_bib19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1210\/jc.84.1.112","article-title":"Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary\u2013testicular axis, and lipid metabolism","volume":"84","author":"Wu","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.contraception.2004.10.001_bib20","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1210\/jc.81.2.757","article-title":"Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach","volume":"81","author":"Bebb","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.contraception.2004.10.001_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1365-2265.2000.01024.x","article-title":"Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasibility study for male contraception","volume":"53","author":"Kamischke","year":"2000","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.contraception.2004.10.001_bib22","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1210\/jc.80.8.2394","article-title":"Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders","volume":"80","author":"Behre","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.contraception.2004.10.001_bib23","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1210\/jc.81.11.4113","article-title":"Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot","volume":"81","author":"Handelsman","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.contraception.2004.10.001_bib24","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/jcem-70-1-282","article-title":"Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production","volume":"70","author":"Matsumoto","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.contraception.2004.10.001_bib25","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/humrep\/15.3.672","article-title":"Oestradiol enhances testosterone-induced suppression of human spermatogenesis","volume":"15","author":"Handelsman","year":"2000","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.contraception.2004.10.001_bib26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1210\/jc.77.2.427","article-title":"Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens","volume":"77","author":"Bagatell","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.contraception.2004.10.001_bib27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.276.8.637","article-title":"Improving the quality of reporting of randomized controlled trials. The CONSORT statement","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2004.10.001_bib28","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2004.10.001_bib29","series-title":"Stedman's Medical Dictionary","author":"Stedman","year":"2000"},{"key":"10.1016\/j.contraception.2004.10.001_bib30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1046\/j.1365-2265.2000.01143.x","article-title":"Erratum: intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasibility study for male contraception","volume":"53","author":"Nieschlag","year":"2000","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.contraception.2004.10.001_bib31","first-page":"1257","article-title":"Empfelhlungen zur nomenklatur in der andologie","volume":"2","author":"Eliasson","year":"1970","journal-title":"Andrologia"},{"key":"10.1016\/j.contraception.2004.10.001_bib32","series-title":"WHO laboratory manual for the examination of human semen and sperm\u2013cervical mucus interaction","year":"1999"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782404002707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782404002707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T04:54:04Z","timestamp":1705985644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782404002707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0010782404002707"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2004.10.001","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}